Banque Transatlantique’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Banque Transatlantique's BMY Position: Q2 2026 in Review
Banque Transatlantique held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 920 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #359.
Banque Transatlantique first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $120K in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Banque Transatlantique held 920 shares of Bristol-Myers Squibb worth $53K as of Q2 2026.
- Banque Transatlantique left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Banque Transatlantique's portfolio in Q2 2026, its #359 holding.
- Banque Transatlantique first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Banque Transatlantique's Bristol-Myers Squibb position peaked at $120K in Q1 2025.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.